These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 990611)

  • 1. Autoradiographic evidence for the effects of specific uptake-inhibitors on the selective accumulation of [3H]-5-HT by supra-ependymal nerve terminals and for the localization of binding sites for [3H]-dLSD.[proceedings].
    Richards JG
    Br J Pharmacol; 1976 Nov; 58(3):424P-425P. PubMed ID: 990611
    [No Abstract]   [Full Text] [Related]  

  • 2. Autoradiographic evidence for the selective accumulation of [3H]5-HT by supra-ependymal nerve terminals.
    Richards JG
    Brain Res; 1977 Sep; 134(1):151-7. PubMed ID: 912413
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake of 5-hydroxytryptamine by Schistosoma mansoni.
    Bennett JL; Bueding E
    Mol Pharmacol; 1973 May; 9(3):311-9. PubMed ID: 4267956
    [No Abstract]   [Full Text] [Related]  

  • 4. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Supra-ependymal "giant"" nerve terminals in rodent brains].
    Arluison M; Bouchaud C; Derer P; Di Marco C
    C R Acad Hebd Seances Acad Sci D; 1976 Jan; 282(4):381-3. PubMed ID: 816566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?
    Raiteri M; Bonanno G; Marchi M; Maura G
    J Pharmacol Exp Ther; 1984 Dec; 231(3):671-7. PubMed ID: 6150107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of lysergic acid derivatives and reserpine on 5-HT binding to nerve ending particles.
    Marchbanks RM
    Biochem Pharmacol; 1967 Oct; 16(10):1971-9. PubMed ID: 6065963
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
    Hrdina PD; Foy B; Hepner A; Summers RJ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cortical infarction reduces [3H]sulpiride binding in rat caudate-putamen: autoradiographic evidence for presynaptic D2 receptors on corticostriate terminals.
    Filloux F; Liu TH; Hsu CY; Hunt MA; Wamsley JK
    Synapse; 1988; 2(5):521-31. PubMed ID: 2973146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of drugs on serotonergic nerve terminals.
    Bloom FE; Costa E
    Adv Cytopharmacol; 1971 May; 1():379-95. PubMed ID: 5163249
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction between neuronal uptake inhibitors and presynaptic serotonin autoreceptors in rat hypothalamic slices: comparison of K+ and electrical depolarization.
    Passarelli F; Galzin AM; Langer SZ
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1056-63. PubMed ID: 2958618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT and LSD high affinity binding sites to brain synaptosomal membranes [proceedings].
    Fillion G; Fillion MP; Jacob J; Rousselle JC
    Br J Pharmacol; 1976 Nov; 58(3):425P-426P. PubMed ID: 990612
    [No Abstract]   [Full Text] [Related]  

  • 13. [3H]tryptamine autoradiography in rat brain and choroid plexus reveals two distinct sites.
    Perry DC
    J Pharmacol Exp Ther; 1986 Feb; 236(2):548-59. PubMed ID: 3003349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptosomal uptake and release of dopamine and 5-hydroxy-tryptamine in the nucleus accumbens in vitro following in vivo administration of lysergic acid diethylamide in rats.
    Hetey L; Quiring K
    Acta Biol Med Ger; 1980; 39(8-9):889-95. PubMed ID: 7282218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On the regulation of tryptophan hydroxylase in brain.
    Zivkovic B; Guidotti A; Costa E
    Adv Biochem Psychopharmacol; 1974; 11(0):19-30. PubMed ID: 4152484
    [No Abstract]   [Full Text] [Related]  

  • 16. Serotoninergic receptors in brain tissue: properties and identification of various 3H-ligand binding sites in vitro.
    Leysen JE
    J Physiol (Paris); 1981; 77(2-3):351-62. PubMed ID: 7288650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of [3H]serotonin from brain slices.
    Chase TN; Katz RI; Kopin IJ
    J Neurochem; 1969 Apr; 16(4):607-15. PubMed ID: 5768216
    [No Abstract]   [Full Text] [Related]  

  • 18. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Displacement of specific serotonin and lysergic acid diethylamide binding by Ergalgin, a new antiserotonin drug.
    Oelszner W
    Acta Biol Med Ger; 1980; 39(8-9):897-901. PubMed ID: 7282219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proceedings: Selective autoradiographic markers for GABA-releasing interneurones and nerve terminals.
    Chapman D; Dick F; Kelly JS
    Br J Pharmacol; 1975 Oct; 55(2):308P-309P. PubMed ID: 1201434
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.